PMS40 - COST – EFFECTIVENESS STUDY OF ETANERCEPT AS FIRST LINE TREATMENT FOR ANKYLOSING SPONDYLITIS IN COLOMBIA
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1754
https://www.valueinhealthjournal.com/article/S1098-3015(18)35056-3/fulltext
Title :
PMS40 - COST – EFFECTIVENESS STUDY OF ETANERCEPT AS FIRST LINE TREATMENT FOR ANKYLOSING SPONDYLITIS IN COLOMBIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35056-3&doi=10.1016/j.jval.2018.09.1754
First page :
Section Title :
Open access? :
No
Section Order :
1116